Engineering Regulatory Requirements

Lifecycle Regulatory Requirements for SaMD in Europe This analysis examines how the EU regulatory framework—MDR 2017/745 and associated standards—maps onto every phase of the Software as a Medical Device (SaMD) lifecycle. It identifies how lifecycle-based oversight shapes development predictability, certification complexity, and long-term maintenance obligations for software-driven medical technologies. Key Takeaways: 1️⃣ Lifecycle compliance relies on a multi-standard architecture. The paper shows that MDR, ISO 14971, ISO 13485, IEC 62304, IEC 62366 and IEC 82304 must be applied together across development, maintenance and post-market phases, forming an integrated compliance stack rather than isolated requirements. 2️⃣ Rule 11 drives higher-risk classification for software. Under MDR Annex VIII Rule 11, many software products transition to higher risk classes, triggering more complex conformity assessment processes and third-party notified-body involvement. 3️⃣ Maintenance and change control are major regulatory burdens. The authors highlight that adaptive, corrective and preventive updates require structured change-control, re-validation when needed, and risk reassessment—making post-market phases as resource-intensive as development. 4️⃣ Post-market surveillance is continuous and multi-layered. PMS requirements include incident reporting, usability monitoring, cybersecurity management, UDI traceability and updates to technical documentation, embedding ongoing regulatory obligations throughout the product lifecycle. Synthesis: The authors conclude that SaMD regulation is fragmented across standards, but becomes coherent when mapped onto lifecycle stages. They identify key risks stemming from unaligned processes, insufficient early planning, and the growing regulatory impact of iterative software modifications. They recommend lifecycle-integrated planning using MDR-aligned standards, structured risk and usability processes, and rigorous post-market surveillance to maintain safety, performance and compliance. ➡️ How should investors factor lifecycle-wide compliance and change-control obligations into valuation models for SaMD companies? 🔗 Source(s): Navigating Regulatory Challenges Across the Life Cycle of a SaMD. Francesconi M., et al. Journal of Biomedical Informatics, 2025. #digitalhealth #healthinvesting #venturecapital #healthcareinnovation #governance

𝗘𝘃𝗲𝗿 𝗳𝗲𝗹𝘁 𝗹𝗶𝗸𝗲 𝘆𝗼𝘂𝗿 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗽𝗮𝘁𝗵𝘄𝗮𝘆 𝗶𝘀 𝗮 𝗯𝗶𝘁 𝘁𝗲𝗻𝘂𝗼𝘂𝘀? If so, you're not alone. When it comes to bringing a medical device to market, the journey can feel anything but straightforward. Here are some actionable steps to make your regulatory path less tenuous and more secure: 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝘁𝗵𝗲 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 → Different regions have different requirements. → For instance, the FDA in the U.S. and the MHRA in the UK have unique criteria. → Knowing the specifics can save you from surprises later on. 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗞𝗲𝘆 → Maintain thorough and organised documentation. → This includes everything from design history files to risk management reports. → Trust me, when an auditor/inspector comes knocking, you'll be thankful for your meticulous records. 𝗞𝗻𝗼𝘄 𝗬𝗼𝘂𝗿 𝗖𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 → Misclassifying your device can lead to major setbacks. → Ensure you understand whether your device falls under Class I, II, or III. → This will dictate the level of regulatory scrutiny your product will face. 𝗘𝗻𝗴𝗮𝗴𝗲 𝗘𝗮𝗿𝗹𝘆 𝘄𝗶𝘁𝗵 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗕𝗼𝗱𝗶𝗲𝘀 → Don't wait until the last minute to interact with regulatory authorities. → Early engagement can provide critical insights and help you avoid common pitfalls. → For example, presubmission meetings with the FDA can be invaluable. 𝗦𝘁𝗮𝘆 𝗨𝗽𝗱𝗮𝘁𝗲𝗱 𝗼𝗻 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 → Regulatory standards are constantly evolving. → Subscribe to industry newsletters and join relevant forums. → Being proactive can often mean the difference between compliance and costly delays. 𝗜𝗻𝘃𝗲𝘀𝘁 𝗶𝗻 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 (𝗤𝗠𝗦) → A robust QMS is not just a regulatory requirement; it’s a business asset. → Implementing standards like ISO 13485 can streamline your processes and improve product quality. 𝗛𝗶𝗿𝗲 𝗼𝗿 𝗖𝗼𝗻𝘀𝘂𝗹𝘁 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝘀 → Don’t hesitate to bring in external expertise. → Regulatory consultants can provide specialised knowledge and help navigate complex requirements. → This can be particularly useful for SMEs with limited in-house resources. Conduct Thorough Testing and Validation → Ensure that all necessary tests are conducted and well documented. → This includes biocompatibility, electrical safety, and performance testing. → Proper validation can prevent last minute hitches during the approval process. Plan for PostMarket Surveillance → Regulatory compliance doesn’t end at market entry. Remember, the regulatory journey might seem tenuous, but with the right approach, you can navigate it successfully.

🧩 Technical Standards every MedTech professionals should know! Whether you're dealing with a Class I device, Class III or building an AI-based SaMD, aligning with the right standards is critical for regulatory success and product quality. But where do you start? Which ones are essential for your compliance? Of course, specific standards depend on device type, intended use, and market. But today I decided to share those standards that form the foundation of regulatory expectations across the industry. 👇 Here's a selection of technical standards every MedTech or regulatory team should be aware of, with recent updates and what’s coming!   🛡️ 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝘀𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 📌 ISO 13485 Medical Devices - Quality Management Systems 📌 ISO 14971 Medical Devices - Risk Management 📌 IEC 62366-1 Medical Devices - Usability Engineering 📌 ISO 10993 series Biological Evaluation for Medical Devices 📌 IEC 60601 Series Electrical Safety Requirements 📌 ISO 15223-1 Medical Devices - Labelling 💻 𝗦𝗼𝗳𝘁𝘄𝗮𝗿𝗲, 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗦𝗲𝗰𝘂𝗿𝗶𝘁𝘆 𝗮𝗻𝗱 𝗔𝗜 📌 IEC 62304 Software Life Cycle Processes 📌 ISO 27001 Information Security Management Systems 📌 ISO 42001 Information technology - Artificial intelligence - Management system 🧪 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻, 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 📌 ISO 14155 Medical Devices - Clinical Investigations 📌 ISO 20916 IVDs – Clinical performance studies 📣📣 What’s New: 📘 ISO 14155:2026 → Clinical investigation of medical devices for human subjects — Good clinical practice → Edition 4, 2026 published in March. 📘 ISO 10993-7:2026 → Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals → Edition 3, 2026 just published. 📘 ISO 20417:2026 → Medical devices - Information to be supplied by the manufacturer → 2026 Edition published, and 2021 officially withdrawn. 📣 What’s Coming: 📘 ISO 18969 → A new standard for clinical evaluation of medical devices → Under development, now in Draft International Standard (DIS) stage. ⚠️ Staying up to date and monitor standards stage is not just good practice, it's essential to ensure compliance as expectations evolve.   New versions may change what's acceptable in risk management, testing, documentation, and more. This is why, on the MedBoard platform regulatory intelligence is not just about regulations and guidance. 👉 Real-time monitoring includes standards updates, adoptions, and country recognitions. So teams can stay informed, all in one place.   💬 Which of these do you use most?   #MedBoard #MedTech #MedicalDevices #RegulatoryAffairs #QualityManagement #RiskManagement  #ClinicalEvaluation #Compliance #ISO13485 #ISO14971 #MDSW #ClinicalAffairs #PostMarketSurveillance

I’m Building a Medical Device—These Are the Experts I Assemble One of the most common reasons for medical device failure? A lack of understanding of regulatory requirements. No matter how innovative the technology, without a clear certification pathway, the device may never reach the market. That’s why assembling the right team isn’t a side task— it’s the foundation of success. You have your engineers and developers ready, now it's time for regulatory affairs. Here are 5 experts I always include when certifying a medical device under the MDR: The PRRC ↳ The Person Responsible for Regulatory Compliance is essential for MDR projects. ↳ They’re the “Swiss Army knife” of regulatory tasks and coordination. ↳ MDR requires strict qualifications and experience for this critical role. The Quality Manager ↳ Proper quality management is non-negotiable in medical device development. ↳ This expert ensures ISO 13485 compliance and manages the QMS. ↳ While MDR doesn’t mandate experience, an effective QMS is essential. The Risk Manager ↳ Risk management impacts nearly all regulatory activities under the MDR. ↳ This expert leads diverse risk teams and ensures robust assessments. ↳ ISO 14971 requires risk managers to have training and experience. The Clinical Expert ↳ Clinical evaluation is one of the most complex aspects of MDR compliance. ↳ They bridge clinical indications and the technology being developed. ↳ 5–10 years of experience in the relevant field is typically required. The Biocompatibility Expert ↳ For most physical devices, biocompatibility is a key development focus. ↳ This expert handles material analysis, toxicology, and biological evaluations. ↳ ISO 10993-1 requires highly trained professionals for these tasks. With these experts, you can develop your device effectively and meet MDR requirements for technical documentation. Remember: A successful medical device project isn’t just about technology. It’s about assembling a team with the right skills to navigate regulatory challenges. P.S. What additional experts would you add to this team? Let’s discuss! ♻️ Find this valuable? Repost for your network. 💡 Follow Bastian Krapinger-Ruether for actionable tips on MedTech compliance and QM. Tired of wasting time on repetitive compliance tasks? DM me to see how AI can automate 70% of your processes, so you can focus on what really matters

MDR Annex II: Ultimate Guide for Organizing Your Technical Documentation Missing crucial regulatory strategies is like building a skyscraper out of paper. There will be a result, but it will not meet expectations. Here is one of my paper-skyscraper experiences: I underestimated how important it is to properly organize a Technical Documentation. Back then, my folders were chaotic—mixing risk management files, clinical data, and product descriptions without a clear structure. This is where Annex II of the EU MDR comes into play. It provides a clear structure for your technical documentation, breaking it into 6 key chapters. Here’s a breakdown of Annex II and how to use it effectively: 1. Device Description and Specification ↳ Define the device’s intended purpose and classification. ↳ Include key design features and technical characteristics. ↳ Think of this as your product’s “business card.” 2. Information to Be Supplied by the Manufacturer ↳ Includes all device labels for single-unit, sales, and transport packaging. ↳ Labels must be provided in the languages accepted by Member States. ↳ Instructions for use (IFU) must also comply with language requirements. 3. Design and Manufacturing Information ↳ Describe development and manufacturing processes ↳ Use flowcharts for clarity and simplicity. ↳ Show alignment between production and quality standards. 4. General Safety and Performance Requirements (GSPRs) ↳ Create a checklist linking evidence to Annex I requirements. ↳ Use a matrix to map compliance for each GSPR. ↳ Highlight key tests and documents supporting each claim. 5. Benefit-Risk Analysis and Risk Management ↳ Follow ISO 14971 principles for risk management. ↳ Show links between risks, mitigations, and residual risks. ↳ Document how benefit outweighs any residual risk. 6. Verification and Validation Data ↳ Provide clinical evaluations and performance testing results. ↳ Include usability studies to show real-world safety. ↳ Prove the device works as intended for its purpose. Why Follow Annex II? When a Technical Documentation is well-organized: → Auditors can quickly find what they need. → Your team works more efficiently during submission preparation. → Regulatory delays are minimized, and certification is faster. For my first project, I learned the hard way. Today, I always organize a Technical Documentation based on Annex II’s chapters—and it’s made all the difference. P.S. Are you organizing your Technical Documentation according to Annex II? Or do you follow a different structure? ---------------------------------- MedTech regulatory challenges can be complex, but smart strategies, cutting-edge tools, and expert insights can make all the difference. I’m Tibor, passionate about leveraging AI to transform how regulatory processes are automated and managed. Let’s connect and collaborate to streamline regulatory work for everyone! #automation #regulatoryaffairs #medicaldevices

⚡️ Ensuring Safety Around Electrical Panels: IEC and Indian Standards ⚡️ Electrical panels are the heart of any facility, but improper clearances can lead to serious hazards like shocks, arc flashes, or fires. Understanding safe working distances is critical for compliance and worker safety. Here’s a quick dive into the requirements under Indian Electricity Rules (IE Rules) and IEC standards, tailored for engineers and facility managers. 🔌 Key Highlights: Indian Standards (IE Rules, IS 732): For low-voltage panels (≤250V), maintain at least 1.0 m front clearance and 0.75 m width. High-voltage panels (>650V–33kV) need 1.5–2.0 m depth, often in separate rooms. These rules prevent ~70% of shock incidents when followed. IEC Standards (60364, 61439): Require 0.7–1.25 m front clearance for ≤1000V panels, with creepage distances (e.g., 8 mm for 1000V) to avoid flashovers in industrial settings. Compliance reduces arc flash risks by up to 80%. Why It Matters: In India, ~20% of electrical fires stem from clearance violations (CEA data). Proper spacing ensures safe access, maintenance, and emergency egress. 🏭 Practical Tips: 1️⃣ Mark clearance zones with tape or signs. 2️⃣ Conduct annual audits (IS 14489) to avoid penalties up to ₹50,000. 3️⃣ Use IEC 61439-compliant panels for global projects. 💡 Stay Safe, Stay Compliant! Are you aligning with these standards in your facility? Share your thoughts or DM me to discuss best practices! #ElectricalSafety #IECStandards #IndianElectricityRules #Engineering #ElectricalEngineering #WorkplaceSafety #DataCenterSafety #EngineeringExcellence #ArcFlashPrevention #FacilityManagement #SafetyFirst

Product development leaders, still bolting on compliance? Proving regulatory compliance at the end of a project is a high-stakes gamble. A single gap can stall delivery, trigger costly delays, or block market entry altogether. One leading electronics manufacturer learned this the hard way. Their products sat on the docks for two months, costing an estimated €110 million, all while they scrambled to prove compliance. Compliance works best when it’s part of the design, not an afterthought. Here’s a 3-step framework to integrate it from the start: 1. Map Requirements Early. Identify all relevant regulations at project kickoff, linking them directly to your product specifications. 2. Embed in PLM. Connect these identified requirements to specific materials, components, and assemblies within your Product Lifecycle Management (PLM) system. 3. Validate Continuously. Leverage your PLM to automatically validate compliance as design decisions are made, ensuring real-time adherence.

🛑 For CTOs and Engineers at ISPs and Construction/Engineering Firms: BEAD's Technical Requirements Aren't Suggestions I've been reviewing BEAD sub-grantee agreements and talking to State Broadband Offices. The technical requirements are stricter than most ISPs expect. Here's what you're contractually committing to for 10+ years: **Performance Standards:** • 100/20 Mbps MEASURED (not advertised) speeds • Latency <100ms (95th percentile) • 99.45% uptime (48-hour max annual outage) • Third-party testing using FCC methodology • Semiannual or annual reporting Example: If you have a 36-hour outage? You've burned 75% of your annual budget. **EHP Compliance:** The big one. Environmental & Historic Preservation clearance takes 3-6 months MINIMUM. **NEPA compliance** Section 106 (SHPO review), ESA Section 7, tribal consultation. Any groundbreaking before clearance = 100% ineligible costs. **Cybersecurity & SCRM:** Initial plan due AT contract execution (not after). And absolutely NO covered equipment: Huawei, ZTE (Rip & Replace) **Build America, Buy America:** Domestic content preference for iron, steel, manufactured products, construction materials. Waivers available, but you need SBO approval BEFORE purchase. The carousel below covers all 5 critical technical areas 👆 Start preparing now. These requirements don't get easier after contract execution. --- #BEAD #NetworkEngineering #BroadbandInfrastructure #Compliance #EHP #Cybersecurity #ISP ---

Here at Innolitics, we like to spread the lessons we've learned for SaMD Developers 🤓 Over the course of serving our clients, we've developed some tips for engaging with the FDA: • Engage Early: Do not wait until regulatory submission. It is important to bring clinicians, patients, and regulatory experts in from day one. • Design for Fit, Not Just Function: Even the best model could fail if it does not fit into existing workflows, or even the already existing infra-structures. • Document Expertise Input: Regulators want proof in the submission package that stakeholder input shaped the device’s design requirements, risk management, usability testing, and labeling. • Keep the Loop Open: Maintain advisory boards and feedback loops post-launch to ensure safe evolution. Overall, the traceability of your regulatory decision is of utmost importance; if you can map each regulatory document back to a stakeholder that influenced the decision, you have created a submission that tells a coherent, trust-building story. You might ask where can you document stakeholder input in regulatory submissions? Here are where regulators expect to see multi-disciplinary influence show up: Design History File: • Show how clinical and patient feedback shaped design inputs. • Keep minutes of advisory board meetings and trace design decisions. User Needs & Design Inputs (part of DHF) • Build a Requirements Traceability Matrix (RTM) linking stakeholder input → requirement → design feature → verification test. Human Factors / Usability File • Document usability studies with intended users (clinicians, patients). • Show design changes made based on real-world feedback. Risk Management File • Capture diverse perspectives: clinical (diagnosis errors), patient (misuse), IT/security (data risks). • Show how risks flagged by different groups were mitigated. Software Development Plan • Record how regulatory and quality experts influenced coding standards, testing, and change management. • Map clinical input into verification scenarios. Clinical Evidence • Show how study design reflected clinical expert advice. • Justify patient population diversity with advisory board input. Labeling & IFU • Capture patient and clinician input on wording, clarity, and instructions. • Document regulatory-driven changes (e.g., disclaimers or limitation statements). Read more about these here: https://hubs.ly/Q03Q8jMx0 #SoftwareEngineering #MedicalDevices #ClinicalWorkflow #FDACompliance